过去一年中添加的文章，按日期排序
… COMBINATION THERAPY OF HIGH-DOSE INTRAVENOUS ANAKINRA AND BARICITINIB IN PATIENTS WITH CRITICAL COVID-19: PROMISING RESULTS FROM …
M Bektaş - 2024 - ard.bmj.com
45 天前 - … be effective in patients with COVID-19 associated cytokine storm. … illness requiring
high flow nasal oxygen supplement. … ICU requirement and mortality did not differ between two …
high flow nasal oxygen supplement. … ICU requirement and mortality did not differ between two …
PHYSIOLOGICAL EFFECTS RELATED TO THE USE OF HIGH-FLOW NASAL CANNULA IN PRETERM INFANTS: INTEGRATIVE REVIEW
JGPG Marques, JMS Rovida, TMM Fernandes… - … of Physical Therapy, 2024 - Elsevier
117 天前 - … of injury to the nasal mucosa, effective alveolar ventilation, … after its use in the
Covid-19 pandemic, and researching it … for use in the Neonatal Intensive Care Unit. Objectives: To …
Covid-19 pandemic, and researching it … for use in the Neonatal Intensive Care Unit. Objectives: To …
ROX index: An important predictor of high-flow nasal cannula and non-invasive ventilation failure
A Chakrabarti, R Kundu, SR Chowdhury - Lung India, 2023 - journals.lww.com
283 天前 - … (COVID-19) pandemic, the use of HFNC has become widely prevalent both inside
and beyond critical care … is an effective adjunct of respiratory support in COPD patients after …
and beyond critical care … is an effective adjunct of respiratory support in COPD patients after …